Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | RUNX3 |
| Upstream (Parents) |
|---|
| (<<) FOXA1 → RUNX3 |
| (<<) EN1 → RUNX3 |
| (<<) FOXC1 → RUNX3 |
| (<<) ANKRD30A → RUNX3 |
| (<<) SPDEF → RUNX3 |
| (<<) SPIB → RUNX3 |
| (<<) EOMES → RUNX3 |
| (<<) CREB3L4 → RUNX3 |
| (<<) TAF4B → RUNX3 |
| (<<) TCF7L1 → RUNX3 |
| (<<) IKZF1 → RUNX3 |
| (<<) IRF1 → RUNX3 |
| (<<) L3MBTL4 → RUNX3 |
| (<<) IRF7 → RUNX3 |
| (<<) TRIM22 → RUNX3 |
| (<<) IRF8 → RUNX3 |
| (<<) STAT2 → RUNX3 |
| Downstream (Children) |
|---|
| RUNX3 → CDKN2A (>>) |
| RUNX3 → FOXQ1 (>>) |
| RUNX3 → GATA3 (>>) |
| RUNX3 → FOXD1 (>>) |
| RUNX3 → TRIM29 (>>) |
| RUNX3 → BCL11B (>>) |
| RUNX3 → BNC1 (>>) |
| RUNX3 → MKX (>>) |
| RUNX3 → DMRT2 (>>) |
| RUNX3 → LHX2 (>>) |
| RUNX3 → EGR3 (>>) |
| RUNX3 → SCML1 (>>) |
| RUNX3 → LMO4 (>>) |
| RUNX3 → NFATC1 (>>) |
| RUNX3 → SLC30A9 (>>) |
| RUNX3 → HR (>>) |
| RUNX3 → PBX1 (>>) |
| RUNX3 → MYCL1 (>>) |
| RUNX3 → SATB1 (>>) |
| RUNX3 → ZNF217 (>>) |
| RUNX3 → ATF5 (>>) |
| RUNX3 → E2F2 (>>) |
| RUNX3 → ZNF281 (>>) |
| RUNX3 → ISX (>>) |
| RUNX3 → ELF4 (>>) |
| RUNX3 → KLF12 (>>) |
| RUNX3 → YY1 (>>) |
| RUNX3 → TFEB (>>) |
| RUNX3 → C11orf9 (>>) |
